Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: XENE) | Delayed: 36.11 -0.39 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.50 | 52 Week High | $9.75 | |||
| Open | $36.25 | 52 Week Low | $5.65 | |||
| Day High | $36.62 | P/E | N/A | |||
| Day Low | $35.91 | EPS | $0.00 | |||
| Volume | 9,399 | |||||
